These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1035908)

  • 1. Hypertrophic obstructive cardiomyopathy prevention of outflow obstruction with propranolol.
    Vijayaraghavan G; Cherian G
    J Assoc Physicians India; 1976 Oct; 24(10):631-6. PubMed ID: 1035908
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic effects of propranolol on obstructive myocardiopathy].
    Ourbak P; Bourdarias JP; Cachin JC; Rocha P; Scebat L; Lenègre J
    Arch Mal Coeur Vaiss; 1971 Mar; 64(3):352-71. PubMed ID: 4397007
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic characteristics of obstructive cardiomyopathy with emphasis on right ventricular outflow obstruction.
    Befeler B; Wells DE; Machado H; Aranda JM
    Angiology; 1979 Jan; 30(1):27-39. PubMed ID: 570812
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for true obstruction to left ventricular outflow in obstructive hypertrophic cardiomyopathy (muscular or hypertrophic subaortic stenosis).
    Wigle ED; Rakowski H
    Z Kardiol; 1987; 76 Suppl 3():61-8. PubMed ID: 3433876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Obstructive myocardiopathy and myocardial metabolism. Effect of rapid atrial electrical stimulation alone and coupled with isoproterenol perfusion].
    Fernández F; Sprogis W; Belfante M; Bourmayan C; Baclet M; Gerbaux A
    Rev Esp Cardiol; 1982; 35(5):423-9. PubMed ID: 6892064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
    Cserhalmi L; Assmann I; Glavanov M; Rev J; Kelecseńeyi Z
    Z Gesamte Inn Med; 1984 Jul; 39(14):330-5. PubMed ID: 6435321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug treatment of hypertrophic cardiomyopathy].
    Hirzel HO
    Herz; 1985 Apr; 10(2):84-90. PubMed ID: 4039293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
    Lösse B; Loogen F; Schulte HD
    Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The course of hypertrophic cardiomyopathy with outflow obstruction in patients under treatment].
    Cserhalmi L; Szabóki F; Csukás I; Ilovszky Z; Huszár G
    Orv Hetil; 1987 Aug; 128(35):1815-23. PubMed ID: 3627783
    [No Abstract]   [Full Text] [Related]  

  • 13. Reappraisal of the effect of acute betablockade on left ventricular filling dynamics in hypertrophic obstructive cardiomyopathy.
    Speiser KW; Krayenbuehl HP
    Eur Heart J; 1981 Feb; 2(1):21-9. PubMed ID: 6115751
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of current ultrasonic study methods for the diagnosis, follow-up of treatment effectiveness and prognosis of patients with hypertrophic obstructive cardiomyopathy].
    Pal L; Fedorova IF; Schäfer R; Sergakova LM; Naumov VG
    Ter Arkh; 1987; 59(10):90-4. PubMed ID: 3433228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated response to exercise in patients with hypertrophic obstructive cardiomyopathy and effect of beta-adrenergic blockade on oxygen transport.
    Edwards RH; Kristinsson A; Warrell DA
    Br Heart J; 1969 May; 31(3):390. PubMed ID: 4396140
    [No Abstract]   [Full Text] [Related]  

  • 16. Transcatheter ablation of septal hypertrophy: a promising alternative to surgery in hypertrophic obstructive cardiomyopathy.
    Keren A; Banai S
    Isr Med Assoc J; 2002 Feb; 4(2):114-6. PubMed ID: 11875983
    [No Abstract]   [Full Text] [Related]  

  • 17. [Factors conditioning the occurrence and entity of intraventricular obstruction in hypertrophic cardiomyopathy].
    Astorri E
    G Ital Cardiol; 1981; 11(8):1141-50. PubMed ID: 7035262
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous loss of left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.
    Oakley CM; Goodwin JF
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():669-75. PubMed ID: 4808085
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
    Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac pacing in obstructive hypertrophic cardiomyopathies].
    Kappenberger L; Aebischer N; Jeanrenaud X
    Ann Cardiol Angeiol (Paris); 1994 Dec; 43(10):573-7. PubMed ID: 7864549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.